Molecular Coordination of Iron Homeostasis by microRNAs
microRNA 对铁稳态的分子协调
基本信息
- 批准号:7939530
- 负责人:
- 金额:$ 43.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnemiaAnimalsApplications GrantsCell physiologyChronic DiseaseCognitiveComputer SimulationDevelopmentDiabetes MellitusDietary IronDiseaseExtramural ActivitiesFoundationsFutureGene ExpressionGene Expression RegulationGoalsHealthHomeostasisImpairmentIn VitroIndividualIronIron deficiency anemiaLaboratoriesLeadLightLiverMaintenanceMalignant NeoplasmsMessenger RNAMetabolismMicroRNAsModelingMolecularMolecular ProfilingMotorNutrientPhysiologicalPopulationPositioning AttributePrevalenceProteinsRNARattusResearchRoleSkeletal MuscleSolidTestingTissuesUnited StatesWorkbiological adaptation to stresscell growth regulationdisorder preventionexperienceimmune functionimpaired capacityin vivoinnovationinsightinterdisciplinary approachiron metabolismnovelprotein expressionpublic health relevanceresponseuptake
项目摘要
DESCRIPTION (provided by applicant): Diseases of iron metabolism continue to be a major health concern in the United States. Iron deficiency remains the most common single nutrient deficiency in the US and individuals experience negative health consequences due to iron deficiency in the absence of anemia, primarily due to alterations in iron metabolism in skeletal muscle. Surprisingly little is known about the molecular mechanisms regulating iron metabolism in skeletal muscle and how alterations in this tissue affects iron homeostasis. The long-term research goal of our laboratory is to advance understanding of how iron metabolism coordinated, and how alterations in iron sensing can lead to the development or prevention of disease. There is evidence suggesting expression of genes involved in iron metabolism is regulated by ID, however, the molecular mechanisms remain poorly characterized. Only recently has the role of small regulatory RNA molecules called microRNAs (miRNAs) been identified as an important mechanism for regulating various cellular processes. Our preliminary in silico analysis of miRNA targets resulted in the identification of mRNAs encoding proteins involved in iron metabolism. Thus our primary objectives are to determine the extent to which expression of miRNAs is regulated in response to ID and to characterize the impact of miRNA expression on potential regulatory targets involved in iron metabolism. We will critically evaluate targets of differentially expressed miRNAs and examine the roles of these targets in cellular iron metabolism. The central hypothesis is that miRNA expression is regulated in response to ID and that changes in expression are associated with changes in the expression target mRNAs resulting in the homeostatic regulation of cellular iron metabolism. To test this hypothesis, this proposal encompasses two specific aims. In Aim 1 we will evaluate and characterize iron-dependent changes in miRNA expression using a weanling rat model of ID. In Aim 2 we will determine the extent to which miRNAs contribute to the regulation cellular iron metabolism through modulating the expression of proteins involved in cellular iron homeostasis. MicroRNA expression profiles in the liver and skeletal muscle will be determined using miRNA microarrays and validated using qPCR. Combining in vivo and in vitro studies, we will identify and characterize target mRNAs and determine the role of these mRNAs in iron metabolism. We will also determine the extent to which changes in miRNA expression are due to alterations in iron status versus alterations in iron sensing. The proposed research is relevant to the maintenance of optimal health in light of the prevalence ID, and by taking an interdisciplinary approach to examine the relationships between iron status and cellular metabolism, we will expand our understanding of how iron contributes to the maintenance of optimal health.
PUBLIC HEALTH RELEVANCE: Iron deficiency continues to be the most common nutrient deficiency and is associated with alterations ranging from impairment in immune function, delayed cognitive development, and decreased capacity of work in skeletal muscle. The focus of this project is to examine the extent to which iron status is associated with alterations in microRNA expression that may contribute to some of the tissue-specific effects of iron deficiency. The results of this study will inform our understanding of the molecular mechanisms coordinating the cellular response to iron deficiency and may have implications in understanding alterations in iron metabolism observed in chronic diseases such as cancer and diabetes.
描述(申请人提供):铁代谢疾病在美国仍然是一个主要的健康问题。缺铁仍然是美国最常见的单一营养素缺乏症,在没有贫血的情况下,个人会因缺铁而产生负面健康后果,主要是由于骨骼肌铁代谢的改变。令人惊讶的是,人们对调节骨骼肌铁代谢的分子机制以及该组织中的变化如何影响铁的动态平衡知之甚少。我们实验室的长期研究目标是促进对铁代谢如何协调的理解,以及铁感应变化如何导致疾病的发展或预防。有证据表明,铁代谢相关基因的表达受ID的调控,但其分子机制尚不清楚。直到最近,被称为microRNAs(MiRNAs)的小调节RNA分子的作用才被确定为调节各种细胞过程的重要机制。我们对miRNA靶标的初步电子分析导致识别出编码与铁代谢有关的蛋白质的mRNAs。因此,我们的主要目标是确定miRNAs的表达在多大程度上受到ID的调控,并表征miRNA表达对参与铁代谢的潜在调控靶点的影响。我们将严格评估差异表达的miRNAs的靶标,并研究这些靶标在细胞铁代谢中的作用。中心假设是miRNA的表达是受ID调节的,表达的变化与表达靶标mRNAs的变化有关,从而导致细胞铁代谢的动态平衡调节。为了检验这一假设,这一提议包含两个具体目标。在目标1中,我们将使用断奶大鼠ID模型来评估和表征miRNA表达的铁依赖变化。在目标2中,我们将通过调节参与细胞铁稳态的蛋白质的表达来确定miRNAs在调节细胞铁代谢中的作用程度。将使用miRNA微阵列确定肝脏和骨骼肌中的microRNA表达谱,并使用qPCR进行验证。结合体内和体外研究,我们将识别和鉴定靶向mRNAs,并确定这些mRNAs在铁代谢中的作用。我们还将确定miRNA表达的变化在多大程度上是由于铁状态的变化与铁感应的变化。这项拟议的研究与根据患病率ID保持最佳健康有关,通过采用跨学科的方法来检查铁状态和细胞代谢之间的关系,我们将扩大我们对铁如何有助于维持最佳健康的理解。
公共卫生相关性:缺铁仍然是最常见的营养缺乏症,并与免疫功能受损、认知发育迟缓和骨骼肌工作能力下降等变化有关。该项目的重点是研究铁状态在多大程度上与microRNA表达的变化有关,这可能有助于缺铁的一些组织特异性影响。这项研究的结果将有助于我们理解协调细胞对缺铁反应的分子机制,并可能对理解在癌症和糖尿病等慢性疾病中观察到的铁代谢的变化有一定的意义。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluation of candidate reference genes for quantitative real-time PCR analysis in a male rat model of dietary iron deficiency.
- DOI:10.1186/s12263-021-00698-0
- 发表时间:2021-10-02
- 期刊:
- 影响因子:3.5
- 作者:Fiddler JL;Clarke SL
- 通讯作者:Clarke SL
Comparisons of the iron deficient metabolic response in rats fed either an AIN-76 or AIN-93 based diet.
喂养 AIN-76 或 AIN-93 饮食的大鼠缺铁代谢反应的比较。
- DOI:10.1186/1743-7075-9-95
- 发表时间:2012
- 期刊:
- 影响因子:4.5
- 作者:Davis,McKaleR;Hester,KristenK;Shawron,KristaM;Lucas,EdralinA;Smith,BrendaJ;Clarke,StephenL
- 通讯作者:Clarke,StephenL
Influence of microRNA on the maintenance of human iron metabolism.
- DOI:10.3390/nu5072611
- 发表时间:2013-07-10
- 期刊:
- 影响因子:5.9
- 作者:Davis M;Clarke S
- 通讯作者:Clarke S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN L CLARKE其他文献
STEPHEN L CLARKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN L CLARKE', 18)}}的其他基金
Prebiotic Activity of Tart Cherry and the Immunoregulation of Bone Homeostasis
酸樱桃的益生元活性和骨稳态的免疫调节
- 批准号:
10046896 - 财政年份:2020
- 资助金额:
$ 43.61万 - 项目类别:
Prebiotic Activity of Tart Cherry and the Immunoregulation of Bone Homeostasis
酸樱桃的益生元活性和骨稳态的免疫调节
- 批准号:
10388465 - 财政年份:2020
- 资助金额:
$ 43.61万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 43.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
- 批准号:
10601679 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别:
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 43.61万 - 项目类别: